老年患者是否应同期行外科房颤消融?
该研究基于2003—2013年汉堡大学心脏中心556例同期行外科房颤消融的患者,术后3、6、12个月以24小时动态心电图或植入式循环记录仪监测心律。结果显示消融安全性良好,无重大消融相关并发症,12个月无房颤率62%~72%且与年龄无关;出院窦性心律与双极消融为成功预测因素,双瓣手术、术前持续性房颤及老年患者合并冠脉搭桥为复发风险因素。
要点
- 老年患者同期外科房颤消融安全有效,无房颤率与年龄无关
- 出院窦性心律和双极消融是消融成功的显著预测因素
- 双瓣手术、术前持续性房颤、老年合并搭桥者复发风险升高
核心结论
- 同期外科房颤消融的安全性和有效性不依赖年龄,老年患者同样可获益。
- 出院窦性心律和双极消融预测消融成功,双瓣手术、术前持续性房颤及老年患者合并冠脉搭桥为复发危险因素。
研究设计与样本
- 2003—2013年单中心队列研究,共556例在汉堡大学心脏中心接受同期外科房颤消融的患者。
- 术后3、6、12个月通过24小时动态心电图(70.5%)或植入式循环记录仪(29.5%)监测心律。
- 主要终点为12个月随访无房颤及年龄与房颤复发风险非线性关联的检测,采用含年龄线性项的多重logistic回归分析。
主要发现
- 患者平均年龄68.4±9.07岁,男性占67.3%,房颤平均病程3.5±3.3年,平均左房内径增大至50.5±8.8 mm。
- 无重大消融相关并发症,30天和1年生存率分别为97.7%和95.8%。
- 总体无房颤率62%~72%,与年龄无关;老年患者合并冠脉搭桥时12个月房颤风险显著升高。
- 多重logistic回归显示双瓣手术(OR 3.48,P=.020)、术前持续性房颤(OR 2.43,P=.001)、老年患者合并冠脉搭桥(OR 2.03,P=.009)为复发危险因素。
- 出院窦性心律(OR 0.39,P<.001)和双极消融(OR 0.32,P<.001)为消融成功的显著预测因素。
关键数值与推荐
- 无房颤率62%~72%,与年龄无关。
- 双瓣手术OR 3.48(P=.020)、术前持续性房颤OR 2.43(P=.001)、老年合并冠脉搭桥OR 2.03(P=.009)为复发危险因素。
- 出院窦性心律OR 0.39(P<.001)、双极消融OR 0.32(P<.001)为成功预测因素。
临床怎么用
- 不应仅因高龄放弃同期外科房颤消融,老年患者同样安全有效。
- 优先采用双极消融并争取出院时恢复窦性心律以提高成功率。
- 对双瓣手术、术前持续性房颤及老年合并搭桥患者应加强术后心律监测与复发管理。
局限性
- 为单中心回顾性队列研究,结果外推需谨慎。
- 心律监测方式不统一(动态心电图与植入式记录仪)可能影响复发检出。
- 随访主要终点为12个月,缺乏更长时期结局数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The incidence of atrial fibrillation increases with age, and therefore many elderly patients presenting for cardiac surgery have atrial fibrillation. In recent publications, increasing age has been recognized as a predictor for ablation failure. Furthermore, many surgeons are reluctant to perform a surgical ablation in elderly patients. We investigated the safety and efficacy of concomitant surgical atrial fibrillation ablation in elderly patients. METHODS: Between 2003 and 2013, 556 patients underwent concomitant surgical atrial fibrillation ablation at the University Heart Center Hamburg and served as our primary study cohort. During follow-up, rhythm monitoring was established by 24-hour Holter electrocardiogram (70.5%) or an implantable loop recorder (29.5%) at 3, 6, and 12 months postoperatively. The primary end point of the study was freedom from atrial fibrillation at 12 months follow-up and the detection of deviations from a linear association between age and risk of atrial fibrillation recurrence. A multiple logistic regression model including age as a linear term was used to identify predictors for rhythm outcome. RESULTS: Mean patients' age was 68.4 ± 9.07 years, and 67.3% of the patients were male. Mean duration of atrial fibrillation was 3.5 ± 3.3 years, and mean left atrium diameters were enlarged with 50.5 ± 8.8 mm. There were no major ablation-related complications. The 30-day and 1-year survivals were 97.7% and 95.8%, respectively. The overall rate of freedom from atrial fibrillation ranged from 62% to 72% and was independent of age. The age-dependent risk of atrial fibrillation at 12 months was significantly increased in elderly patients undergoing a concomitant coronary artery bypass grafting surgery. Multiple logistic regression model revealed double valve procedures (odds ratio, 3.48; P = .020), preoperative persistent atrial fibrillation (odds ratio, 2.43; P = .001), and coronary artery bypass grafting surgery in elderly patients (odds ratio, 2.03; P = .009) as risk factors for recurrence of atrial fibrillation. Sinus rhythm at discharge (odds ratio, 0.39; P < .001) and bipolar ablation (odds ratio, 0.32; P < .001) were significant predictors for successful ablation. CONCLUSIONS: Surgical atrial fibrillation ablation was safe and effective independently of age. Sinus rhythm at discharge and bipolar ablation were significant predictors for successful ablation, whereas double valve procedures, preoperative persistent atrial fibrillation, and coronary artery bypass grafting surgery in elderly patients were risk factors for recurrence of atrial fibrillation.
引用
- Petersen J, Vettorazzi E, Hakmi S, et al. Should concomitant surgical ablation for atrial fibrillation be performed in elderly patients? J Thorac Cardiovasc Surg. 2019. PMID: 31932056. doi:10.1016/j.jtcvs.2019.10.186
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。